Se connecter S'abonner en ligne
  • Company news
  • Fund news
  • E-Mail alert service
  • Notre offre
 Languages  By theme  By sector  By country
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Turkiye Garanti Bankasi A.S. [US9001487019]   
[23/08/2019]

Turkiye Garanti Bankasi A.S. : Turkiye Garanti Bankasi A.S.: TR0GRAN013F5 ISIN-Redemption of the Structured Note

Turkiye Garanti Bankasi A.S. TGBD Turkiye Garanti Bankasi A.S.: TR0GRAN013F5 ISINRedemption of the Structured Note 23Aug2019 / 12:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. TO: Investment Community FROM : Garanti BBVA / Investor Relations SUBJECT: TR0GRAN013F5 ISINRedemption of the... See more
 
Turkiye Garanti Bankasi A.S. [US9001487019]   
[23/08/2019]

Turkiye Garanti Bankasi A.S. : Turkiye Garanti Bankasi A.S.: TR0GRAN013L3 ISIN-Redemption of the Structured Note

Turkiye Garanti Bankasi A.S. TGBD Turkiye Garanti Bankasi A.S.: TR0GRAN013L3 ISINRedemption of the Structured Note 23Aug2019 / 12:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. TO: Investment Community FROM : Garanti BBVA / Investor Relations SUBJECT: TR0GRAN013L3 ISINRedemption of the... See more
 
ad pepper media International N.V. [NL0000238145/APM]   
[23/08/2019]

ad pepper media International N.V. : Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy

OriginalResearch: ad pepper media International N.V. von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu ad pepper media International N.V. Unternehmen: ad pepper media International N.V. ISIN: NL0000238145 Anlass der Studie: Update Empfehlung: Buy seit: 23.08.2019 Kursziel: 3,30 Euro Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: 19.07.2019... See more
 
OJSC Surgutneftegas [US8688612048/SGN]   
[23/08/2019]

OJSC Surgutneftegas : 'Surgutneftegas' PJSC: Statement of a significant fact 'Information on income paid on the issuer's equity securities'

Surgutneftegas PJSC SGGD Surgutneftegas PJSC: Statement of a significant fact Information on income paid on the issuers equity securities 23Aug2019 / 08:46 CET/CEST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION EU No 596/2014 MAR, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Statement[1]... See more
 
MBB Industries AG [DE000A0ETBQ4/MBB]   
[23/08/2019]

MBB Industries AG : MBB SE grows revenues in first half-year and increases forecast after recent acquisition

DGAPAdhoc: MBB SE / Key words: Half Year Results MBB SE grows revenues in first halfyear and increases forecast after recent acquisition 23Aug2019 / 08:16 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure of... See more
 
MBB Industries AG [DE000A0ETBQ4/MBB]   
[23/08/2019]

MBB Industries AG : MBB SE steigert Umsatz im ersten Halbjahr und erhöht Prognose nach jüngster Akquisition

DGAPAdhoc: MBB SE / Schlagworte: Halbjahresergebnis MBB SE steigert Umsatz im ersten Halbjahr und erhöht Prognose nach jüngster Akquisition 23.08.2019 / 08:16 CET/CEST Veröffentlichung einer Insiderinformationen nach Artikel 17 der Verordnung EU Nr. 596/2014, übermittelt durch DGAP ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent /... See more
 
BIOPHYTIS [FR0012816825/ALBPS]   
[23/08/2019]

BIOPHYTIS : Biophytis has signed €24m bond funding from Negma to continue the development of its drug candidates to treat neuromuscular diseases

Press Release Biophytis has signed EUR24m bond funding from Negma to continue the development of its drug candidates to treat neuromuscular diseases Paris, 23rd August 2019, 08.00am CET - BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specialized in developing new therapeutics to slow the degenerative processes and improve functional outcomes for... See more
 
Aumann AG [DE000A2DAM03/DE000A2D]   
[23/08/2019]

Aumann AG : Aumann AG: Aumann experiences investment restraint of automotive market in first half-year, but increases E-mobility revenues

DGAPNews: Aumann AG / Key words: Quarterly / Interim Statement Aumann AG: Aumann experiences investment restraint of automotive market in first halfyear, but increases Emobility revenues 23.08.2019 / 07:32 The issuer is solely responsible for the content of this announcement. Beelen, 23 August 2019 Aumann AG \Aumann\, ISIN: DE000A2DAM03 matched previous years revenue level at EUR133.5... See more
 
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...


Videos
Gestionnaires,
Emetteurs,
My favourite companies
Most read news